Resistance of bacteria to antimicrobial agents leads to the increase of strongest bacteria strains capable of causing dangerous infections. Scientists are challenged creating new antibiotics for bacteria that continuously increase their resistance. Nanotechnology provides innovative alternatives for treatments. This study shows the antimicrobial effects of enhanced antibiotics with MgO and CuO nanoparticles. Our goal is to develop more effective treatments against resistant bacteria, and nosocomial infections, developing new enhanced antimicrobial agents using nanoparticles. Three antibiotics, Gentamicin, Ciprofloxacin, and Cephalexin, at two different concentrations were used against Escherichia coli (ATCC # 10536), Staphylococcus aureus (ATCC # BAA-1026), and Pseudomonas aeruginosa. (ATCC #  10145      ). Our results revealed the impact of specific concentrations of antibiotics comparing to  concentrations of antibiotics mixed with nanoparticles.

Antimicrobial activity of enhanced antibiotics mixed with MgO, and CuO nanoparticles

247th National Meeting (2014)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.